Morgan Stanley
KURE icon

Morgan Stanley’s KraneShares MSCI All China Health Care Index ETF KURE Stock Holding History

Morgan Stanley’s Portfolio KURE Stock Details KURE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$55K Sell
3,220
-2,142
-40% -$37.9K ﹤0.01% 6389
2025
Q4 		$91.4K Sell
5,362
-3,687
-41% -$70.5K ﹤0.01% 6241
2025
Q3 		$189K Buy
9,049
+3,751
+71% +$73.8K ﹤0.01% 5919
2025
Q2 		$89.6K Buy
5,298
+1,699
+47% +$27K ﹤0.01% 6175
2025
Q1 		$56.1K Sell
3,599
-4,591
-56% -$67.2K ﹤0.01% 6231
2024
Q4 		$116K Sell
8,190
-2,017
-20% -$31.4K ﹤0.01% 5998
2024
Q3 		$171K Buy
10,207
+8,228
+416% +$112K ﹤0.01% 5810
2024
Q2 		$26.2K Sell
1,979
-486
-20% -$7K ﹤0.01% 6372
2024
Q1 		$35.8K Sell
2,465
-24,377
-91% -$376K ﹤0.01% 6331
2023
Q4 		$469K Sell
26,842
-97,756
-78% -$1.75M ﹤0.01% 5640
2023
Q3 		$2.21M Sell
124,598
-2,892
-2% -$51.5K ﹤0.01% 4327
2023
Q2 		$2.3M Buy
127,490
+19,914
+19% +$397K ﹤0.01% 4332
2023
Q1 		$2.21M Sell
107,576
-55,474
-34% -$1.24M ﹤0.01% 4400
2022
Q4 		$3.49M Buy
163,050
+67,453
+71% +$1.32M ﹤0.01% 4050
2022
Q3 		$1.69M Buy
95,597
+934
+1% +$19.5K ﹤0.01% 4546
2022
Q2 		$2.21M Sell
94,663
-318
-0.3% -$6.69K ﹤0.01% 4452
2022
Q1 		$2.21M Sell
94,981
-23,197
-20% -$570K ﹤0.01% 4445
2021
Q4 		$3.39M Sell
118,178
-138,809
-54% -$4.77M ﹤0.01% 4130
2021
Q3 		$9.61M Buy
256,987
+21,097
+9% +$822K ﹤0.01% 2935
2021
Q2 		$10.7M Buy
235,890
+78,455
+50% +$3.34M ﹤0.01% 2893
2021
Q1 		$6.13M Buy
157,435
+32,413
+26% +$1.33M ﹤0.01% 3200
2020
Q4 		$4.88M Buy
125,022
+9,121
+8% +$323K ﹤0.01% 3281
2020
Q3 		$3.89M Buy
115,901
+113,101
+4,039% +$3.87M ﹤0.01% 2962
2020
Q2 		$89K Buy
+2,800
New +$76.8K ﹤0.01% 5461

Other funds holding KURE

VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
OMC
Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
OWP
ORG Wealth Partners Dallas, Texas $667M AUM 45.16% 1-Year Est. Return

Morgan Stanley's KURE Position: Q1 2026 in Review

Morgan Stanley reduced its KraneShares MSCI All China Health Care Index ETF (KURE) stake by 40% in Q1 2026, selling an estimated $37.9K and leaving 3,220 shares worth $55K. The position accounts for ﹤0.01% of the portfolio, ranked #6389.

Morgan Stanley first reported a position in KURE in Q2 2020 and has held it in 24 quarters since. The position peaked at $10.7M in Q2 2021. 16 funds tracked by Wall St. Rank hold KURE as of Q1 2026.

  • Morgan Stanley held 3,220 shares of KraneShares MSCI All China Health Care Index ETF worth $55K as of Q1 2026.
  • Morgan Stanley sold 2,142 KraneShares MSCI All China Health Care Index ETF shares in Q1 2026, an estimated $37.9K.
  • KraneShares MSCI All China Health Care Index ETF made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #6389 holding.
  • Morgan Stanley first reported a position in KraneShares MSCI All China Health Care Index ETF in Q2 2020 and has held it in 24 quarters since.
  • Morgan Stanley's KraneShares MSCI All China Health Care Index ETF position peaked at $10.7M in Q2 2021.
  • 16 funds tracked by Wall St. Rank held KraneShares MSCI All China Health Care Index ETF as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.